stockrow
Saturday 7 November 2026
Export CRBU’s income statement to Excel — free account
Caribou Biosciences, Inc.
CRBU Healthcare Biotechnology
Caribou Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 million, up 11.7% from fiscal 2024.
- Revenue
- −26.9%
- EPS
- +16.7%
- Free cash flow
- +84.8%
Quarter to September 2026, against a year earlier
0.44
0.03
+7.32%
Follow CRBU
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 3 | 3 |
+8 more TTM periods Free account |
| (93.80%) | (78.27%) | (83.46%) | (78.97%) | ||
| (64.44%) | (56.87%) | (63.04%) | (60.62%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(120.84%) | (99.31%) | (122.41%) | (117.02%) | |
Average Days of Receivables |
0.00 | 48.67 | 54.47 | 64.53 | |
Free Cash Flow per Share |
(0.87) | (1.31) | (1.06) | (1.20) | |
Free Cash Flow |
(93.11) | (132.79) | (101.64) | (112.35) | |
Capital Expenditures |
— | (37.01) | (0.39) | (1.36) | |
| Other line items | |||||
Cash ROIC |
(54.31%) | (63.11%) | (46.27%) | (42.96%) | |
Accounts Receivable Turnover |
0.00 | 5.96 | 6.22 | 5.49 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
897.05% | 854.70% | 843.69% | 980.72% | |
Selling, General and Administrative Expense of Revenue |
343.51% | 336.20% | 323.53% | 339.76% | |
Share Based Compensation of Revenue |
103.08% | 104.66% | 99.57% | 113.63% | |
Operating CF/Net income |
0.91 | 0.93 | 0.76 | 0.75 | |
Depreciation/Fixed assets |
0.38 | 0.34 | 0.35 | 0.37 | |
Capex/Depreciation |
0.00 | (19.70) | (0.18) | (0.54) | |
Revenue per Share |
0.09 | 0.10 | 0.12 | 0.12 | |
Operating CF per Share |
(0.87) | (0.95) | (1.06) | (1.19) | |
Capex per Share |
0.00 | (0.37) | 0.00 | (0.01) | |
Capex to Sales |
0.00 | 3.69 | 0.03 | 0.12 |
Columns are period end dates · fundamentals updated 5 Nov 2026